Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Posttranslational processing of proglucagon and postsecretory fate of proglucagon products. / Holst, Jens Juul; Ørskov, C.; Hartmann, Bolette; Deacon, C.F.

    The Insulinotropic Gut Hormone Glucagon-like Peptide-1.. Basel : Karger, 1997. p. 24-48.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  2. Published

    Non-insulin-dependent diabetes mellitus - new drugs? / Holst, Jens Juul.

    In: Drug Discovery Today, No. 2, 1997, p. 128-129.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. / Larsen, Philip J.; Tang-Christensen, M.; Holst, Jens Juul; Ørskov, C.

    In: Neuroscience, No. Vol. 77, No. 1, 1997, p. 257-270.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Glucagon-like peptide-1 (GLP-17-36amide) reduces hepatic glucose production indirectly through changes in insulin and glucagon secretion. / Larsson, H.; Holst, Jens Juul; Ahrén, Bo.

    In: Acta Phys. Scand., No. 160, 1997, p. 413-422.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Altered postprandial motility in chronic pancreatitis: role of malabsorption. / Layer, P.; v.d. Ohe, M.R.; Grandt, D.; Holst, Jens Juul; Jansen, J.B.M.J.; Holtmann, G.; Keller, J.; Goebell, H.

    In: Today in Medicine. Gastroenterology, No. 112, 1997, p. 1624-1634.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. / Nauck, M A; Niedereichholz, U; Ettler, R; Holst, J J; Orskov, C; Ritzel, R; Schmiegel, W H.

    In: American Journal of Physiology (Consolidated), Vol. 273, No. 5 Pt 1, 11.1997, p. E981-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Glucagon-like peptide-1 (GLP-1) as a new therapeutic approach for type-2 diabetes. / Nauck, M.A.; Holst, Jens Juul; Willms, B.; Schmiegel, W.

    In: Exp. Clin. Endocrinol. Diabetes, No. 105, 1997, p. 187-195.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Effects of GLP-1 on gastric and pancreatic exocrine secretion and on gastrointestinal motility. / Nauck, M.A.; Schepp, W.; Holst, J.J.; Schmiegel, W.H.

    The Insulintropic Gut Hormone Glucagon-Like Peptide-1, Front Diabetes vol. 13. Basel : Karger, 1997. p. 194-206.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  9. Published

    Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. / Näslund, E.; Grybäck, P.; Hellström, P.M.; Jacobsson, H.; Holst, Jens Juul; Theodorsson, E.; Backmann, L.

    In: International Journal of Obesity, No. 21, 1997, p. 387-392.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    The release of gastric inhibitory peptide, glucagon-like peptide-1, and insulin after oral glucose test in colectomized subjects. / Palnæs Hansen, C.; Andreassen, J.; Holst, J.J.

    In: Scandinavian Journal of Gastroenterology, No. 32, 1997, p. 473-477.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207